Home arrow Latest News arrow Therapeutics arrow Diseases arrow Metabolic disorders arrow Metabolic Endocrinology-Diabetic Neuropathy Drug Pipeline Report
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.

Therapeutics arrow Diseases arrow Metabolic disorders arrow Metabolic Endocrinology-Diabetic Neuropathy Drug Pipeline Report

Metabolic Endocrinology-Diabetic Neuropathy Drug Pipeline Report


Price: $995.00


Detailed information on the current drug pipeline. This report provides insight into the pipeline status of diabetic neuropathy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

* Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
* Keep track of your competitors and partners by better understanding their product pipeline.
* Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
* Maintain a critical competitive advantage.

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Diabetic Neuropathy Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Legend
--Top 20 companies in late stage Diabetic Neuropathy Projects
--Top 20 companies in early stage Diabetic Neuropathy Projects
Full Pipeline View
--Pre Clinical Pipeline View
--Phase II Pipeline View

Pages: 7


LSA Drug Pipeline Reports

View all available LSA Drug Pipeline Reports

Drug Pipeline Update Reports from BioSeeker

View all available Drug Pipeline Update Reports from BioSeeker




:

 


Download Fax Order Form/ PO Form

Request free sample pages from this product















Featured Products


Future Focus: Gastrointestinal Stromal Tumor
$26 250.00
$19 687.50
You Save: 25.00%

Future Focus: Myelodysplastic Syndrome
$26 250.00
$19 687.50
You Save: 25.00%

Cancer Drug Resistance 2008
$2 995.00
$2 396.00
You Save: 20.00%

Cancer Stem Cells: Emerging Therapeutic, Diagnostic and Market
$3 350.00
$2 680.00
You Save: 20.00%

Search Products

Advanced Search

Your Cart

Show Cart
Your Cart is currently empty.
Advertisement
 
 
 
© 2008 BioMarket Group